Cardinal Health, Inc. provided preliminary guidance for fiscal year 2025. For the period, the company expects Non-GAAP Diluted EPS At least $7.50.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
96.54 USD | -1.25% |
|
-6.39% | -4.23% |
Jun. 14 | Merit Medical is recalling unauthorized plastic syringes, US FDA says | RE |
Jun. 14 | Deutsche Bank Adjusts Cardinal Health Price Target to $115 From $110 | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.23% | 23.51B | |
+26.32% | 75.86B | |
+15.24% | 8.76B | |
+1.47% | 8.31B | |
-33.21% | 6.66B | |
+18.93% | 5.45B | |
+1.65% | 4.05B | |
-8.73% | 3.8B | |
-9.28% | 3.33B | |
+8.56% | 3.22B |
- Stock Market
- Equities
- CAH Stock
- News Cardinal Health, Inc.
- Cardinal Health, Inc. Provides Preliminary Earnings Guidance for Fiscal Year 2025